Testing effectiveness (Phase 2)Study completedNCT02676843
What this trial is testing
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
Who this might be right for
Frontotemporal Lobar Degeneration (FTLD)Frontotemporal Dementia (FTD)Tauopathies
Columbia University 7